Category | Patient characteristics | Biopsies (%) | Cell lines (%) | Xenografts (%) |
---|---|---|---|---|
Total nr of samples | Â | 76 (100) | 13 (100) | 18 (100) |
Institution | LUMC, Netherlands | 29 (38.2) | 0 (0) | 0 (0) |
 | IOR, Italy | 11 (14.5) | 7 (53.8) | 0 (0) |
 | LOH, Sweden | 3 (3.9) | 0 (0) | 0 (0) |
 | Radiumhospitalet, Norway | 1 (1.3) | 3 (23.1) | 12 (66.7) |
 | UV, Spain | 0 (0) | 0 (0) | 6 (33.3) |
 | WWUM, Germany | 32 (42.1) | 0 (0) | 0 (0) |
 | Other | 0 (0) | 3 (23.1) | 0 (0) |
Origin | Biopsy | 76 (100) | 0 (0) | 0 (0) |
 | Resection | 0 (0) | 7 (53.8) | 11 (61.1) |
 | Metastasis | 0 (0) | 3 (23.1) | 1 (5.6) |
 | Unknown | 0 (0) | 3 (23.1) | 6 (33.3) |
Location of primary tumor | Femur | 36 (47.4) | 0 (0) | 10 (55.6) |
 | Tibia/fibula | 26 (34.2) | 0 (0) | 2 (11.1) |
 | Humerus | 10 (13.2) | 0 (0) | 2 (11.1) |
 | Axial skeleton | 1 (1.3) | 0 (0) | 1 (5.6) |
 | Unknown/other | 3 (3.9) | 13 (100) | 3 (16.7) |
Histological subtype | Osteoblastic | 50 (65.8) | 9 (69.2) | 15 (83.3) |
 | Chondroblastic | 9 (11.8) | 0 (0) | 3 (16.7) |
 | Fibroblastic | 7 (9.2) | 4 (30.8) | 0 (0) |
 | Minor | 10 (13.2) | 0 (0) | 0 (0) |
Histological response to pre-operative chemotherapy in the primary tumor | Good response | 33 (43.4) | 0 (0) | 0 (0) |
 | Poor response | 36 (47.4) | 0 (0) | 0 (0) |
 | Unknown/NA | 7 (9.2) | 13 (100) | 18 (100) |
Sex | Male | 52 (68.4) | 9 (69.2) | 9 (50) |
 | Female | 24 (31.6) | 4 (30.8) | 3 (16.7) |
 | Unknown | 0 (0) | 0 (0) | 6 (33.3) |